# The HEADWIND Study - Part 4

> **NCT05308095** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 10 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **OTHER:** Controlled hypoglycaemic state while driving

## Key facts

- **NCT ID:** NCT05308095
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-13
- **Primary completion:** 2022-06-23
- **Final completion:** 2022-06-23
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-12-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05308095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05308095, "The HEADWIND Study - Part 4". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05308095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*